Active Shortage

PACLITAXEL FOR INJECTION USP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PACLITAXEL FOR INJECTION USP in Canada?

Yes. PACLITAXEL FOR INJECTION USP 6MG has an active shortage reported to Health Canada (last updated October 5, 2017).

When will PACLITAXEL FOR INJECTION USP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file4 products · 2 same form & route

Affected strength6MG

Report last updated2017-10-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PACLITAXEL FOR INJECTION

BIOLYSE PHARMA CORPORATION

6MG · DIN 02244372

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PACLITAXEL INJECTION USP

SANDOZ CANADA INCORPORATED

6MG · DIN 02320150

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ABRAXANE FOR INJECTABLE SUSPENSION

BRISTOL-MYERS SQUIBB CANADA

100MG · DIN 02281066

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL

PANACEA BIOTEC PHARMA LIMITED

100MG · DIN 02496097

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02320010

Strength

6MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

PACLITAXEL

Tier

Unrated

Last Updated

2017-10-05

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890